Stella has raised $10.0M in total across 1 funding round.
Stella's investors include Andreessen Horowitz, Bain Capital Ventures, Bowery Capital, CRV, Curie.Bio, Zachary Bogue, Equity Alliance, Felicis Ventures, First Round Capital, Flex Capital, Fortress Investment Group, Founder Collective.
Stella Technology is a Silicon Valley-based digital healthcare company founded in 2012, specializing in cloud-based electronic medical records (EMR), telehealth solutions, and healthcare interoperability services.[1][2][3] Its flagship product, Equinox, is a virtual care platform that unifies data silos to deliver accessible, affordable high-quality care globally, serving providers, payers, and patients while optimizing workflows through big data analytics and systems integration.[1][5][6] With approximately 151 employees and annual revenue around $12-14.6 million, the company solves critical problems in health information exchange (HIE), enabling efficient data access and insights amid growing healthcare complexity.[2][3]
Stella also offers end-to-end software development services, from product ideation and UI/UX design to scalable architecture deployment, leveraging two decades of healthcare IT expertise for tailored solutions.[4][5][6]
Stella Technology was founded in 2012 in Milpitas, California, by Lalo Valdez, who serves as Co-Founder, President, and CEO.[2] Emerging from the need to simplify access to quality healthcare in a fragmented data landscape, the company pioneered HIE and interoperability solutions, building on expertise in health information management.[1][3] Early focus centered on telemedicine tools, big data techniques, and machine learning to enhance communication and decision-making at points of care, achieving initial traction through custom deployments for healthcare organizations.[2][4] Pivotal growth came from developing the Stella Prism platform for advanced analytics and the Equinox EMR/telehealth suite, securing modest funding of about $423,000 across rounds while expanding to 151 employees.[2][3]
Stella rides the digital health transformation wave, addressing surging demand for interoperable EMR/telehealth amid post-pandemic virtualization and AI-driven analytics.[1][4] Timing aligns with regulatory pushes like FHIR standards and market forces favoring cloud scalability to cut costs and enhance care equity, especially in underserved global regions.[2][6] By empowering data harness for providers and payers, Stella influences the ecosystem through custom integrations, fostering efficient HIE that reduces silos and supports value-based care trends.[3][5]
Stella's momentum positions it for expansion in AI-enhanced telehealth and predictive analytics, potentially scaling Equinox via partnerships amid rising global healthcare digitization.[1][4] Trends like machine learning integration and social determinants of health will shape growth, evolving its influence from niche integrator to broader platform leader in accessible care.[2][5] As digital healthcare demand accelerates, Stella's focused expertise could drive significant adoption, reinforcing its mission that healthcare is a fundamental right.[6]
Stella has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Seed in September 2016.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2016 | $10.0M Seed | Andreessen Horowitz, Bain Capital Ventures, Bowery Capital, CRV, Curie.Bio, Zachary Bogue, Equity Alliance, Felicis Ventures, First Round Capital, Flex Capital, Fortress Investment Group, Founder Collective, Great Oaks Venture Capital, Khosla Ventures, Matrix, NFX, Operator Partners, Quiet Capital, Race Capital, Rally Ventures, Relay Ventures, R-Squared Ventures, Sinai Ventures, Susa Ventures, The Finger Group, Vine Ventures LP, Visionaire Ventures, Brian Distelburger, David Yaffe, Dennis Crowley, Emil Michael, Farzad Nazem, Gil Hirsch, Gokul Rajaram, Jim Pallotta, Joshua Schachter, Marc Benioff, Mike Kourey, Noosheen Hashemi, Pierre Valade, Ran Makavy, Roger Ehrenberg, Shlomo Kramer, Tirto Adji, Wiley Cerilli |
